MDFA News

Macula Month 2022

We kick off Macula Month celebrating a huge win for the macular disease community, as the major political parties reject a 69 per cent rebate cut for sight-saving eye injections.

Back

Most popular

“I don’t feel so alone anymore”

MDFA offers Peer to Peer phone calls as well as peer support groups, both face-to-face and online.

Forced to hang up her knitting needles

Sadly, eye injections came too late for Cheryl Chamberlain. But thousands of Australian patients will now be able to stick to this sight-saving treatment after both major political parties rejected a proposed Medicare rebate cut.

It’s a relief

Anne and 47,000 other Australians are relieved a proposed Medicare rebate cut for eye injections has been rejected.

The sight of 47,000 older Australians has been saved

Eye injections saved Uncle Gerald’s sight. Now both major parties’ have rejected a recommended rebate cut, an additional 47,000 older Australians will keep their vision too.

Rebate cut rejected

The Government and Opposition reject a cut to the Medicare rebate for sight-saving eye injections, which threatened to blind 47,000 Australians.

It’s good news for people on a pension

The rejection of the proposed Medicare rebate cut is good news, “especially for people on a pension”, says Joe from Queensland.

Proposed Medicare rebate cut rejected

A win for the macular disease community as major political parties reject a Medicare rebate cut for sight-saving eye injections.

I’m so relieved

Mike says the rejection of a proposed cut in the Medicare rebate for eye injections means he can get on with life and not have to worry about the cost of maintaining his sight.

Vision Voice: Read our latest newsletter

On the cover of the Vision Voice Autumn 2022 newsletter, you’ll read how MDFA is making your voice heard ahead of the Federal Election.

MDFA launches eye health video series

MDFA has released a new series of educational videos to help Aussies better understand macular disease.

Third anti-VEGF agent reimbursed by PBS

Beovu has become the third anti-VEGF drug to be subsidised by the Pharmaceutical Benefits Scheme for the treatment of wet AMD.

Potential new treatment for dry AMD

Apellis announces initial results from two phase III studies in geographic atrophy.

“I don’t feel so alone anymore”

MDFA offers Peer to Peer phone calls as well as peer support groups, both face-to-face and online.

Forced to hang up her knitting needles

Relief after rebate cut rejected

Eye injections have saved the sight of thousands of Aussies since this vital treatment arrived here 15 years ago – including Magdalena from the Gold Coast.

It’s a relief

Anne and 47,000 other Australians are relieved a proposed Medicare rebate cut for eye injections has been rejected.

Macula Matters

The Macula Month edition of Macula Matters, MDFA’s newsletter for healthcare professionals.

The sight of 47,000 older Australians has been saved

Eye injections saved Uncle Gerald’s sight. Now both major parties’ have rejected a recommended rebate cut, an additional 47,000 older Australians will keep their vision too.

Rebate cut rejected

The Government and Opposition reject a cut to the Medicare rebate for sight-saving eye injections, which threatened to blind 47,000 Australians.

It’s good news for people on a pension

The rejection of the proposed Medicare rebate cut is good news, “especially for people on a pension”, says Joe from Queensland.

Proposed Medicare rebate cut rejected

A win for the macular disease community as major political parties reject a Medicare rebate cut for sight-saving eye injections.

MDFA News

Macula Month 2022

Most popular

Most recent

Follow us

Newsletter sign-up

Thank you.Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring your patient to MDFA for non-clinical support and macular disease information. We will make contact with them within five business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about MDFA’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

There are no items to display.

Please broaden your search.

Thank you.
Your contact form has been successfully submitted.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters: